Opiant Pharmaceuticals Inc
(OPNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 11,259 | 6,387 | 9,924 | 9,106 | 6,313 |
| Gross Profit | 11,259 | 6,387 | 9,924 | 9,106 | 6,313 |
| Operating Expenses | 9,013 | 8,712 | 10,938 | 8,379 | 6,544 |
| Operating Income | 2,247 | -2,325 | -1,014 | 727 | -232 |
| Interest Expense | 542 | 537 | 0 | 0 | 0 |
| Other Income | -21 | 17 | -136 | -2 | 15 |
| Pre-tax Income | 1,684 | -2,844 | -1,150 | 725 | -216 |
| Income Tax | N/A | N/A | -465 | N/A | N/A |
| Net Income Continuous | 1,684 | -2,844 | -686 | 725 | -216 |
| Net Income | $1,684 | $-2,844 | $-686 | $725 | $-216 |
| EPS Basic Total Ops | 0.39 | -0.66 | -0.16 | 0.17 | -0.05 |
| EPS Basic Continuous Ops | 0.39 | -0.66 | -0.16 | 0.17 | -0.05 |
| EPS Diluted Total Ops | 0.31 | -0.66 | -0.14 | 0.15 | -0.05 |
| EPS Diluted Continuous Ops | 0.31 | -0.66 | -0.14 | 0.15 | -0.05 |
| EPS Diluted Before Non-Recurring Items | 0.31 | -0.66 | N/A | N/A | N/A |
| EBITDA(a) | $2,346 | $-2,225 | $-482 | $759 | $-208 |